FDA advisory committee to discuss strain-specific COVID-19 vaccines
The FDA advisory committee is meeting today to discuss whether a strain-specific COVID-19 vaccine should be in the works and how soon it could made available to the public.
News 12 Staff
•
Jun 28, 2022, 4:04 PM
•
Updated 666 days ago
Share:
More Stories
1:55
New national standard to limit PFAS in drinking water
3ds ago1:13
CDC: Children ER visits increased last 3 years for accidental melatonin ingestion
3ds ago
Guide: Alcohol addiction recovery support and resources
8ds ago4:39
Guide: Ways to help you identify and deal with work burnout
9ds ago2:04
CDC: Most women do not get a mammogram because of financial difficulties
9ds ago2:00
Connecticut woman says Krav Maga can benefit one's physical and mental health
17ds ago1:55
New national standard to limit PFAS in drinking water
3ds ago1:13
CDC: Children ER visits increased last 3 years for accidental melatonin ingestion
3ds agoGuide: Alcohol addiction recovery support and resources
8ds ago4:39
Guide: Ways to help you identify and deal with work burnout
9ds ago2:04
CDC: Most women do not get a mammogram because of financial difficulties
9ds ago2:00
Connecticut woman says Krav Maga can benefit one's physical and mental health
17ds agoThe FDA advisory committee is meeting today to discuss whether a strain-specific COVID-19 vaccine should be in the works and how soon it could made available to the public.
The current COVID vaccines are based on the virus that emerged in late 2019.
Experts are looking at whether one vaccine should specifically target the Omicron variant.
Health officials anticipate COVID vaccines will need to be administered annually, like the flu shot.
